Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER-2 Positive Breast Cancer|Metastatic Neoplasm
Interventions: BIOLOGICAL: Margetuximab|BIOLOGICAL: Trastuzumab|DRUG: Physician's choice of chemotherapy.
Sponsor: MacroGenics